Salience Learning Announced as a Finalist for the 2023 LTEN Excellence Awards
New York, NY – April 4, 2023 – Salience Learning is pleased to announce that it has been named as a finalist for the 2023 LTEN (Life Sciences Trainers & Educators Network) Excellence Awards in the Industry Partnership category. The firm was selected as a finalist because of one of its learning programs, Critical Thinking Academy.
Critical Thinking Academy is a digital learning program (with optional instructor-led components) designed to help professionals in the life science industry enhance their critical thinking capabilities. Critical thinking is increasingly essential to success in a range of roles within biopharma companies. The academy is part of a suite of offerings that also includes Generating Insights Academy and Strategic Thinking Academy.
These programs are available in role-specific versions. They use the latest in learning science and incorporate e-learning, micro-learning, instructor-led components, practice plans, and social learning. Often underpinned by Eurekos’ LMS platform, they are part of biopharmaceutical companies’ Learning and Development offerings to help upskill and reskill their team members for success.
The Excellence Award finalists will be recognized at the LTEN annual meeting in Phoenix, June 12-15. Winners will be announced at an awards ceremony on June 14.
About Salience Learning
Salience Learning (www.saliencelearning.com) is a learning and development (L&D) firm that empowers change across the life science industry through learning. Its team of adult education experts and experienced biopharma professionals apply science-based educational approaches to help solve the industry’s most complex business challenges. The firm offers a series of role-specific academies that develop critical capabilities for industry professionals. It also develops custom learning solutions and provides strategic consulting services in L&D. Salience Learning is a subsidiary of Blue Matter Consulting and serves clients globally.
# # #
For more information, contact: